MEILLEUREHEALTH (02327) Schedules 27 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express

Mar 12

Meilleure Health International Industry Group Limited (stock code: 02327) has announced that its board of directors will convene on 27 March 2026.

The meeting’s agenda includes: 1. Reviewing and approving the consolidated financial results for the financial year ended 31 December 2025. 2. Considering a recommendation on the payment of a final dividend, if any.

Key timeline: • Board-meeting notice issued: 12 March 2026 • Results period under review: FY2025 (year ended 31 December 2025) • Scheduled board meeting: 27 March 2026

Board composition as at the announcement date: • Executive Directors: Zhou Xuzhou, Dr. Zeng Wentao, Zhou Wen Chuan (also Chief Executive Officer) • Non-executive Director: Dr. Mao Zhenhua • Independent Non-executive Directors: Professor Chau Chi Wai, Wilton; Chen Shi; Wu Peng

The company will release its audited FY2025 results and any dividend decision following the 27 March 2026 board meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1176549609"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176549609\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176549609?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176549609","market":"us","top_or_hot":-1,"title":"MEILLEUREHEALTH (02327) Schedules 27 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Meilleure Health International Industry Group Limited (stock code: 02327) has announced that its board of directors will convene on 27 March 2026.</p>\n<p>The meeting’s agenda includes:  \n1. Reviewing and approving the consolidated financial results for the financial year ended 31 December 2025.  \n2. Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>Key timeline:  \n• Board-meeting notice issued: 12 March 2026  \n• Results period under review: FY2025 (year ended 31 December 2025)  \n• Scheduled board meeting: 27 March 2026</p>\n<p>Board composition as at the announcement date:  \n• Executive Directors: Zhou Xuzhou, Dr. Zeng Wentao, Zhou Wen Chuan (also Chief Executive Officer)  \n• Non-executive Director: Dr. Mao Zhenhua  \n• Independent Non-executive Directors: Professor Chau Chi Wai, Wilton; Chen Shi; Wu Peng</p>\n<p>The company will release its audited FY2025 results and any dividend decision following the 27 March 2026 board meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEILLEUREHEALTH (02327) Schedules 27 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEILLEUREHEALTH (02327) Schedules 27 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-12 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Meilleure Health International Industry Group Limited (stock code: 02327) has announced that its board of directors will convene on 27 March 2026.</p>\n<p>The meeting’s agenda includes:  \n1. Reviewing and approving the consolidated financial results for the financial year ended 31 December 2025.  \n2. Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>Key timeline:  \n• Board-meeting notice issued: 12 March 2026  \n• Results period under review: FY2025 (year ended 31 December 2025)  \n• Scheduled board meeting: 27 March 2026</p>\n<p>Board composition as at the announcement date:  \n• Executive Directors: Zhou Xuzhou, Dr. Zeng Wentao, Zhou Wen Chuan (also Chief Executive Officer)  \n• Non-executive Director: Dr. Mao Zhenhua  \n• Independent Non-executive Directors: Professor Chau Chi Wai, Wilton; Chen Shi; Wu Peng</p>\n<p>The company will release its audited FY2025 results and any dividend decision following the 27 March 2026 board meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02327","symbol_name":"美瑞健康国际","start_time":0,"source_url":"","article_id":"1176549609","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176549609","pubTimestamp":1773308624,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Meilleure Health International Industry Group Limited (stock code: 02327) has announced that its board of directors will convene on 27 March 2026. The meeting’s agenda includes:   1. Reviewing and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02327":"美瑞健康国际"},"translate_title":"MEILLEUREHEALTH(02327)定于2026年3月27日召开董事会会议，批准2025财年业绩和股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02327":1},"content_text":"Meilleure Health International Industry Group Limited (stock code: 02327) has announced that its board of directors will convene on 27 March 2026.\nThe meeting’s agenda includes:  \n1. Reviewing and approving the consolidated financial results for the financial year ended 31 December 2025.  \n2. Considering a recommendation on the payment of a final dividend, if any.\nKey timeline:  \n• Board-meeting notice issued: 12 March 2026  \n• Results period under review: FY2025 (year ended 31 December 2025)  \n• Scheduled board meeting: 27 March 2026\nBoard composition as at the announcement date:  \n• Executive Directors: Zhou Xuzhou, Dr. Zeng Wentao, Zhou Wen Chuan (also Chief Executive Officer)  \n• Non-executive Director: Dr. Mao Zhenhua  \n• Independent Non-executive Directors: Professor Chau Chi Wai, Wilton; Chen Shi; Wu Peng\nThe company will release its audited FY2025 results and any dividend decision following the 27 March 2026 board meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}